Novel thrombin and factor Xa inhibitors: challenges to reversal of their anticoagulation effects.
about
Designing allosteric inhibitors of factor XIa. Lessons from the interactions of sulfated pentagalloylglucopyranosides.Allosteric inhibition of factor XIa. Sulfated non-saccharide glycosaminoglycan mimetics as promising anticoagulants.Coagulation factor XI vaccination: an alternative strategy to prevent thrombosis.Plasma Exchange for Urgent Apixaban Reversal in a Case of Hemorrhagic Tamponade after Pacemaker Implantation.Therapeutic Plasma Exchange for Urgent Rivaroxaban Reversal.
P2860
Novel thrombin and factor Xa inhibitors: challenges to reversal of their anticoagulation effects.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Novel thrombin and factor Xa i ...... their anticoagulation effects.
@en
type
label
Novel thrombin and factor Xa i ...... their anticoagulation effects.
@en
prefLabel
Novel thrombin and factor Xa i ...... their anticoagulation effects.
@en
P1476
Novel thrombin and factor Xa i ...... their anticoagulation effects
@en
P2093
Ravi Sarode
P304
P356
10.1097/MOH.0B013E328365A164
P50
P577
2013-11-01T00:00:00Z